Protein-based vaccine candidate combined with potent adjuvant yields effective SARS-CoV-2 protection

A new protein-based vaccine candidate combined with a potent adjuvant provided effective protection against SARS-CoV-2 when tested in animals, suggesting that the combination could add one more promising COVID-19 vaccine to the list of candidates for human use. The protein antigen, based on the receptor binding domain (RBD) of SARS-CoV-2, was expressed in yeast instead…

Details